KMC Speciality Q1 FY27 Results (NSE: KMCSHIL)
Signal: Margin expansion
The read
The key inflection is operating margin expansion to 23.05%, up 531bps YoY as revenue grew 34.99% while employee and other operating expenses grew 15.02%; however, PAT growth of 122.74% to ₹1,641.39 lakh is less recurring in quality because other income rose 75.75% YoY to ₹1,133.16 lakh.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹82.25 Cr | 34.99% | +1.98% |
| EBIT | ₹13.11 Cr | +129.08% | |
| Net profit | ₹16.41 Cr | +122.74% | |
| EPS | ₹1.02 | +121.74% | |
| EBIT margin | 23.05% |
P&L walk
Standalone revenue rose to ₹8,225.31 lakh, up 34.99% YoY and 1.98% QoQ; gross margin expanded 184bps YoY and EBITDA margin rose to 23.05%, while PAT growth to ₹1,641.39 lakh was amplified by ₹1,133.16 lakh of other income.
Key positives
- Revenue from operations reached ₹8,225.31 lakh, up 34.99% YoY and 1.98% QoQ, maintaining strong top-line momentum.
- Gross margin expanded 184bps YoY to 84.82% as material-related costs declined to 15.18% of revenue from 17.02%; the filing does not identify the cause.
- EBITDA grew 76.00% YoY to ₹1,896.12 lakh versus revenue growth of 34.99%, a +41.01pp growth gap, while EBITDA margin expanded 531bps to 23.05%.
- Employee benefits expense grew 27.56% YoY and depreciation grew 15.14%, both below the 34.99% revenue growth rate, supporting fixed-cost absorption.
- Finance costs declined 7.46% YoY to ₹200.27 lakh, providing additional support to pre-tax earnings.
Key concerns
- Other income increased 75.75% YoY to ₹1,133.16 lakh and represented approximately 50.50% of reported PBT of ₹2,243.82 lakh, making the 122.74% PAT growth less representative of underlying operations.
- The filing provides no hospital operating KPIs such as occupancy, ARPOB, bed additions or case volumes, limiting assessment of whether the 34.99% revenue growth is volume- or price-led.
Research and educational content only. Not investment advice.